Brichant G, Potorac I, Petignot S, Tebache L, Pintiaux A, Nisolle M, Beckers A
Service d'Endocrinologie, CHU Liège, Belgique.
Service d'Endocrinologie, CHU Liège, Belgique - Service de Gynécologie, CHU Liège, Belgique.
Rev Med Liege. 2020 Sep;75(9):604-612.
The polycystic ovary syndrome is one of the most frequent endocrine disorders in women of reproductive age. The first signs and symptoms of the disease may be present as early as puberty. Diagnostic criteria include hyperandrogenism (clinical or biological), ovulatory dysfunction and polycystic ovarian morphology on ultrasound. The consequences of the syndrome are multiple. These consist of fertility issues and metabolic anomalies with increased cardiovascular risk, but also sleep disturbances, increased risk of endometrial hyperplasia and endometrial cancer and a potentially important psychological impact with decreased quality of life. The management of polycystic ovary syndrome is multidisciplinary and treatment is variable, depending on symptoms and the patient's desire for fertility. In all cases, measures aiming to improve the metabolic dysfunction are essential, going from adopting a healthy lifestyle to adequate therapy of each metabolic anomaly.
多囊卵巢综合征是育龄期女性最常见的内分泌疾病之一。该病最早的体征和症状可能在青春期就已出现。诊断标准包括高雄激素血症（临床或生物学表现）、排卵功能障碍以及超声检查显示的多囊卵巢形态。该综合征的后果是多方面的。这些后果包括生育问题和代谢异常，心血管风险增加，还包括睡眠障碍、子宫内膜增生和子宫内膜癌风险增加，以及对生活质量有潜在重要影响的心理问题。多囊卵巢综合征的管理是多学科的，治疗方法因人而异，取决于症状以及患者的生育意愿。在所有情况下，旨在改善代谢功能障碍的措施至关重要，从采取健康的生活方式到对每种代谢异常进行适当治疗。
